Nosocomial Pneumonia in Intubated Patients Given Sucralfate as Compared with Antacids or Histamine Type 2 Blockers

New England Journal of Medicine

Volumn 317, Issue 22, 1987, Pages 1376-1382

  Driks, Michael R ^a   Craven, Donald E ^a   Celli, Bartolome R ^a   Manning, Marie ^a   Burke, Robert A ^a   Garvin, Gail M ^a   Kunches, Laureen M ^a   Farber, Harrison W ^a   Wedel, Suzanne A ^a   McCabe, William R ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUCRALFATE;

ACINETOBACTER; CITROBACTER; ESCHERICHIA COLI; HAEMOPHILUS INFLUENZAE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; PNEUMONIA; PSEUDOMONAS AERUGINOSA; STOMACH PH; STRESS ULCER;

ANTACIDS; BACTERIAL INFECTIONS; COMPARATIVE STUDY; CROSS INFECTION; FEMALE; GASTRIC ACIDITY DETERMINATION; GRAM-NEGATIVE BACTERIA; HISTAMINE H2 ANTAGONISTS; HUMAN; MALE; MIDDLE AGE; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PHARYNX; PNEUMONIA; RANDOM ALLOCATION; RESPIRATION, ARTIFICIAL; STOMACH; SUCRALFATE; TRACHEA;

EID: 0023612057     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198711263172204     Document Type: Article

References (41)

1. Horan TC, White JW, Jarvis WR, et al. Nosocomial infection surveillance, 1984. MMWR CDC Surveill Summ 1986; 35(1):17SS–29SS.
2. Haley RW, Hooton TM, Culver DH, et al. Nosocomial infections in U.S. hospitals, 1975–1976: estimated frequency by selected characteristics of patients. Am J Med 1981; 70: 947–59.
3. Gross PA, Neu HC, Aswapokee P, Van Antwerpen C. Aswapokee N. Deaths from nosocomial infection: experience in a university hospital and a community hospital. Am J Med 1980; 68: 219–23.
4. Lepper MH. Opportunistic gram-negative rod pulmonary infections. Dis Chest 1963; 44: 18–26.
5. Tillotson JR, Finland M. Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. J Infect Dis 1969; 119: 597–624.
6. Johanson WG, Pierce AK, Sanford J, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 1972; 77: 701–6.
7. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients: emergence of gram-negative bacilli. N Engl J Med 1969; 281: 1137–40.
8. LeFrock JL, Ellis CA, Weinstein L. The relation between aerobic fecal and oropharyngeal microflora in hospitalized patients. Am J Med Sci 1979; 277: 275–80.
9. Valenti WM, Trudell RG, Bentley DW. Factors predisposing to oropharyngeal colonization with gram-negative bacilli in the aged. N Engl J Med 1978; 298: 1108–11.
10. Higuchi JH, Chaudhui T, Johanson WG. Determinants of postoperative respiratory tract colonization with gram-negative bacilli. Am Rev Respir Dis 1978; 117: Suppl: 274. abstract.
11. Louria DB, Kaminski T. The effects of four antimicrobial drug regimens on sputum superinfection in hospitalized patients. Am Rev Respir Dis 1962; 85: 649–65.
12. Sprunt K, Redman W. Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora. Ann Intern Med 1968; 68: 579–90.
13. Spray SB, Zuidema GD, Cameron HL. Aspiration pneumonia: incidence of aspiration with endotracheal tubes. Am J Surg 1976; 131: 701–3.
14. Atherton ST, White DJ. Stomach as source of bacteria colonising respiratory tract during artificial ventilation. Lancet 1978; 2: 968–9.
15. du Moulin GC, Paterson DG, Hedley-Whyte J, Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonisation of the airway. Lancet 1982; 1: 242–5.
16. Goularte TA, Lichtenberg DA, Craven DE. Gastric colonization in patients receiving antacids and mechanical ventilation: a mechanism for pharyngeal colonization. Am J Infect Control 1986; 14: 88.
17. Daschner F, Kapstein I, Engels I, et al. Stress ulcer prophylaxis and ventilation pneumonia: prevention by antibacterial cytoprotective agents? Infect Control (in press).
18. Pingleton SK, Hinthorn DR, Liu C. Enteral nutrition in patients receiving mechanical ventilation: multiple sources of tracheal colonization include the stomach. Am J Med 1986; 80: 827–32.
19. Zinner MJ, Zuidema GD, Smith PL, Mignosa M. The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obstet 1981; 153: 214–20.
20. Harris SK, Bone RC, Ruth WE. Gastrointestinal hemorrhage in patients in a respiratory intensive care unit. Chest 1977; 72: 301–4.
21. Schuster DP, Rowley H, Feinstein S, McGue MK, Zuckerman GR. Perspective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med 1984; 76: 623–30.
22. Priebe HJ, Skillman JJ, Bushnell LS, Long PC, Silen W. Antacid versus cimetidine in preventing acute gastrointestinal bleeding: a randomized trial in 75 critically ill patients. N Engl J Med 1980; 302: 426–30.
23. Ruddell WSJ, Axon ATR, Findlay JM, Bartholomew BA, Hill MJ. Effect of cimetidine on the gastric bacterial flora. Lancet 1980; 1: 672–4.
24. Snepar R, Poporad GA, Romano JM, Kobasa WD, Kaye D. Effect of cimetidine and antacid on gastric microbial flora. Infect Immun 1982; 36: 518–24.
25. Donowitz LG, Page MC. Mileur BL, Guenthner SH. Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infect Control 1986; 7: 23–6.
26. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133: 792–6.
27. Borrero E, Mangolis IB, Bank S, Shulman N, Chardavoyne R. Antacid versus sucralfate in preventing acute gastrointestinal bleeding: a randomized trial in 100 critically ill patients. Am J Surg 1984; 148: 809–12.
28. Tryba M, Zevounou F, Torok M, Zeuz M. Prevention of acute stress bleeding with sucralfate, antacids, or cimetidine: a controlled study with pirenzepine as a basic medication. Am J Med 1985; 79: Suppl 2C 55–61.
29. Borrero S, Bank S, Margolis I, Schulman ND, Chardavoyne R. Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill. Am J Med 1985; 79: Suppl 2C: 62–4.
30. Samloff IM, O'Dell C. Inhibition of peptic activity by sucralfate. Am J Med 1985; 79: Suppl 2C: 15–8.
31. Schneider JS, Ouellette MS. Sucralfate administration via nasogastric tube. N Engl J Med 1984; 310: 990.
32. Jennett B. Assessment of the severity of head injury. J Neurol Neurosurg Psychiatry 1976; 39: 647–55.
33. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818–29.
34. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, N.J.: Prentice-Hall, 1984.
35. Martin LF, Max MH, Polk HC Jr. Failure of gastric pH control by antacids or cimetidine in the critically ill: a valid sign of sepsis. Surgery 1980; 88: 59–68.
36. Cross AS, Roup B. Role of respiratory assistance devices in endemic nosocomial pneumonia. Am J Med 1981; 70: 681–5.
37. Craven DE, Driks MR. Pneumonia in the intubated patient. Semin Respir Infect 1987; 2: 20–33.
38. Tryba M. Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care unit patients; sucralfate versus antacids. Am J Med 1987; 83: Suppl 3B: 117–24.
39. Rigaud D, Chastre J, Accary JP, Bonfils S, Gibert C, Hance AJ. Intragastric pH profile during acute respiratory failure in patients with chronic obstructive pulmonary disease: effect of ranitidine and enteral feeding. Chest 1986; 90: 58–63.
40. Pierce AK, Sanford JP, Thomas GD, Leonard JS. Long-term evaluation of decontamination of inhalation-therapy equipment and the occurrence of necrotizing pneumonia. N Engl J Med 1970; 282: 528–31.
41. Reinarz JA, Pierce AK, Mays BB, Sanford JP. The potential role of inhalation therapy equipment in nosocomial pulmonary infection. J Clin Invest 1965; 44: 831–9.